33 hours ago All Military Health System Direct Care Direct care refers to military hospitals and clinics, also known as “military treatment facilities” and “MTFs.” direct care facilities must report qualifying patient safety events to the DoD Patient Safety Program through Joint Patient Safety Reporting.Self-reporting is one of the key components in the MHS’s effort to achieve high … >> Go To The Portal
Kratom use will not produce a positive result on a routine DoD drug test. Regardless, Military Service Members are prohibited from using any product containing kratom, given its safety concerns. Kratom is on the OPSS list of DoD-prohibited substances.
Your DoD Patient Safety Program (PSP) is a complete program with the goal of creating a culture of patient safety and quality within the Military Health System (MHS).
FDA has concerns about “kratom’s potential for abuse, addiction, and serious health consequences; including death.” In fact, there has been an increase in reported deaths associated with kratom use since November 2017.
Joint Patient Safety Reporting All Military Health System Direct Care Direct care refers to military hospitals and clinics, also known as “military treatment facilities” and “MTFs.” direct care facilities must report qualifying patient safety events to the DoD Patient Safety Program through Joint Patient Safety Reporting
The DoD Patient Safety Program eBulletin provides you with patient safety news, leading practices from across the Military Health System, tips you can use and upcoming educational activities to ensure the patient safety community remains informed and active.
Sharing information is the key to ensuring all DoD patient care teams have one vision for patient safety. We offer solutions that help teams continuously learn and develop skills to reduce risk and provide high quality care to patients.
A Patient Safety Awareness Week parking lot banner hangs at the main entrance of the Defense Health Agency in Falls Church, Virginia during the week of 10-16 March 2019 , showing that “We All Play a Role in Healthcare Safety”.
Your DoD Patient Safety Program (PSP) is a complete program with the goal of creating a culture of patient safety and quality within the Military Health System (MHS). We encourage a systems approach to creating a safer patient environment; engaging MHS leadership; promoting collaboration across all three services; and fostering trust, transparency, teamwork, and communication.
A newly revised suite of tools and resources for military health care providers will help improve the treatment of service members with concussions, and ensure their safe return to full duty.
The implementation of the new electronic health record MHS GENESIS. system, expected to be completed in 2023, also will be closely monitored via JPSR. , an evidence-based framework of skills for improving patient safety through a comprehensive suite of ready-to-use materials, tools, and training materials.
FDA’s statement from 25 June 2019: “ FDA issues warnings to companies selling illegal, unapproved kratom drug products marketed for opioid cessation, pain treatment and other medical uses .”. FDA’s statement from 27 November 2018: “… risk of heavy metals, including nickel and lead, found in some kratom products.”.
Kratom ( Mitragyna speciosa korth) is a tropical tree from Southeast Asia. Its leaves contain chemicals that can have mind-altering effects. In the U.S., kratom is sometimes marketed as a dietary supplement, but it’s often sold as a legal herbal drug in powder and capsule forms. It also can be prepared as a tea (the traditional method) or as an extract in some other liquid. Some people use it as an alternative treatment for conditions such as pain, anxiety, depression, and opioid use disorder. However, at this time, there are no FDA-approved uses of kratom.
Kratom use will not produce a positive result on a routine DoD drug test. Regardless, Military Service Members are prohibited from using any product containing kratom, given its safety concerns. Kratom is on the OPSS list of DoD-prohibited substances.
In fact, there has been an increase in reported deaths associated with kratom use since November 2017. FDA has a well-developed process for evaluating botanical drug products, but “To date, no marketer has sought to properly develop a drug that includes kratom.”.
Kratom often is marketed as a “safe” treatment for some serious health conditions, but kratom contains compounds that “make it so it isn’t just a plant – it’s an opioid.”. FDA has concerns about “kratom’s potential for abuse, addiction, and serious health consequences; including death.”.
“FDA has exercised jurisdiction over kratom as an unapproved drug, and has also taken action against kratom-containing dietary supplements.”. Kratom often is marketed as a “safe” treatment for some serious health conditions, ...
Currently, kratom is not a controlled substance, although the U.S. Drug Enforcement Agency (DEA) considers it a “drug of concern.”. In countries where it is grown, it is chewed or made into a tea to counteract fatigue or reduce anxiety. The dose is important.